GSK Drops Diversity Targets Amid Backlash
FDA AdCom Meeting on Flu Vaccines Canceled
CDC A(H5N1) Bird Flu Response Update February 26, 2025; Confirmed 3 Human Cases Of H5 Bird Flu In People Who Became Ill In 2025 - Website
Measles Outbreak in Texas Claims First Life
U.S. to Spend up to $1B for Bird Flu Response
Zymeworks Achieves $14 Million in Milestone Payment From GSK Partnership
Top Gap Ups and Downs on Tuesday: LI, PHG, MSTR and More
UK's FTSE 100 Starts New Week Flat; GSK Gains
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
Peering Into GSK's Recent Short Interest
GSK Closes Up to $1 Billion Purchase of US-based IDRx
GSK Completes Acquisition of IDRx
GSK PLC GSK Completes Acquisition of IDRx, Inc.
GSK PLC Starts Buyback Program
GSK Plc Commences Share Buyback Programme
GSK Plc (GSK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
Trump Tells Big Pharma to Bring Production Home or Face Tariffs: Bloomberg News
GlaxoSmithKline (GSK.US) has submitted a new drug for COPD for market approval in China.
GlaxoSmithKline (GSK.US) announced that the National Medical Products Administration has accepted the new drug application for IL-5 monoclonal antibody Nucala (mepolizumab).
GSK Announces Dr Gavin Screaton to Join the Board as Non-Executive Director
First Meeting of CDC Vaccine Advisory Panel Under RFK Jr. Postponed